Madrid Declaration on Ozone Therapy
(ISCO3, 4th edition, 2025)
English & Spanish
Available now in the following two languages:
English, digital: 196 pages. 150€. For viewing only; cannot be copied, printed, or downloaded.
Spanish, printed: 189 pages. 150€ + shipping costs
* The digital version in English is for viewing only; cannot be copied, printed, or downloaded.
Very soon it will be available digital in Portuguese and Spanish.
Later in digital version: Italian, Spanish. Within the following months: In other different languages. The 3rd. edition (2020) was translated into 10 different languages.
Its very high number of translations into different languages makes it a unique reference document for the scientific practice of ozone therapy worldwide.
The importance of the “Madrid Declaration on Ozone Therapy”
“For the Unification of Criteria in the Practice of Ozone Therapy”
The 4th edition (2025) is a comprehensively expanded and fully updated version that covers:
– Human Medicine
– Dentistry
– Veterinary Medicine (for small and large animals)
This edition compiles scientific research from around the world, the result of years of experience and clinical practice.
Ozone therapists from many different countries contributed to this edition, fostering a global dialogue to improve clinical outcomes and scientific standards.
The Madrid Declaration on Ozone Therapy is the only truly global reference document on ozone therapy.
Its numerous translations into different languages make it a unique reference document for the study, dissemination, and scientific practice of ozone therapy worldwide.
The Declaration serves as a reference and guide for healthcare professionals. The application of its recommendations depends on the clinical judgment of each health professional
It is a living document, which has been in effect for 15 years, being reviewed by ISCO3 every five years (2010, 2015, 2020, 2025). The 4th edition was approved by ISCO3 on April 18, 2025.
1st Edition (2010). English: 24 pages. Spanish: 25 pages.
2nd Edition (2015). English: 50 pages. Spanish: 50 pages.
3rd Edition (2020). English: 102 pages. Spanish: 106 pages.
4th Edition (2025). English (digital): 195 pages. Spanish (printed): 189 pages
Officially presented at the “4th International Congress of the Madrid Declaration on Ozone Therapy, 4th ed.” at the ICOMEM (Illustrious Official College of Physicians of Madrid, similar to a State Medical Board of the USA) on June 5, 2025
Expansions and updates of the Declaration
With each new edition, the Declaration grows in scientific topics and content, bibliographic references, and pages. The 4th edition includes the addenda for Dentistry and Veterinary Medicine (the latter contains sections on “small animals” and, for the first time, “large animals”).
ISCO3 carries out very important research to ensure that each edition of the Declaration helps to realize the publication’s logo: “Towards the Unification of Criteria in the practice of ozone therapy.” True to this logo, the 4th edition is a comprehensively expanded and fully updated version reflecting the very important scientific advances that ozone therapy has had in recent years.
* The digital version in English is for viewing only; cannot be copied, printed, or downloaded.
Index of the Declaration
MADRID DECLARATION ON OZONE THERAPY
ISCO3,4th, ed., 2025
“For the Unification of Criteria in the Practice of Ozone Therapy”
Official ISCO3 Document
INDEX
- EDITIONS OF THE DECLARATION
1st Edition (2010, 19 pages)
2nd Edition (2015, 50 pages)
3rd Edition (2020, 102 pages)
4th Edition (2025, 196 pages)
- AUTHORS
- ISCO3 members that approved the Declaration on April 18, 2025
- WHO IS ISCO3?
- Main Objectives of ISCO3
- DISCLAIMER
- Why is a 4th Edition of the Madrid Declaration Necessary?
- CONCLUSIONS
- RECOMMENDATION
- ACKNOWLEDGEMENTS
———–
HUMAN MEDICINE
THERAPEUTIC RANGES FOR THE USE OF OZONE
INDEX
- THERAPEUTIC BASES
- Growth of Scientific Publications on Ozone Therapy
1.2 Costs and Economic Benefits of Ozone Therapy
1.3 Ozone therapy, a Complementary Technique, not an Alternative
1.4 Ozone Therapist
1.5. Medical Ozone Generators (MOG)
1.6. Dose-Effect Relationship
1.7. Therapeutic Window
1.8. Materials Used in Ozone Therapy
1.9. Mechanism of Ozone Action
1.10. Redox Bioregulator
1.11. Nutrient Supplementation for Patients Before Receiving Systemic Ozone Therapy
1.12. Most Common Routes of Local Ozone Application
2.1. Contraindications
2.2. Warning
2.4. Synergistic effects with other oxidative therapies
2.5. Adverse Effects
2.5.1 Grade 1 medium
2.5.2 Grade 2 moderate
2.5.3 Grade 3 severe
2.5.4 Grade 4.
2.5.5 Grade 5.
2.6. Toxicity
2.7. Dosage in Pediatrics by Rectal Insufflation (RIO3)
- MAIN SYSTEMIC APPLICATION ROUTES
3.1. Major Autohemotherapy (MAH)
3.2. Minor Autohemotherapy (MiAH)
3.3. Ozonated Saline Solution Solution (O3SS)
3.3.1. Can O3SS Generate Toxic Compounds?
3.3.2. O3SS Preparation Methods
3.3.3. Propeties of Microbubbling
3.3.4. Recommended Doses
3.3.5. Calculation of Concentration for O3SS
3.3.6. Indications for use of doses
3.3.7. Adverse Effects of O3SS
3.4. Extracorporeal Blood Oxygenation (EBOO)
3.5. Rectal Insufflation (RIO3)
3.6. Vaginal Insufflation
4.1. Intramuscular, Paravertebral and Facet Infiltration
4.2. Intramuscular Paravertebral Infiltration
4.3. Hernias and Facet Infiltration
4.4. Intradiscal Infiltration
4.5. Infiltration of the Sacral Hiatus
4.6. Intraforaminal Infiltration
4.7. Coxofemoral Infiltration
4.8. Knee infiltration
4.9. Subcutaneous Emphysema Technique (Glove Technique)
4.10. Bagging
5.1. Facial Acne
5.2. Rosacea Acne
5.3. Atopic Dermatitis
5.4. Acute Cutaneous Abscess
5.5. Fungal Infections of the Skin, Hair, and Nails: Ringworm and Candida
5.6. Psoriasis
5.7. Fistula insufflation
- APPLICATION IN AESTHETICS
6.1. Subcutaneous application for the treatment of cellulite
6.2. Facial Infiltration
6.3. Ozone Application with Hoods
- VESICOURETHRAL LAVAGE
- PROSTATE TREATMENT WITH OZONE
- OTIC ROUTE
- OPHTHALMOLOGICAL PATHWAY WITH OZONE
- INTRATONSILLAR INFILTRATION
- MICRODOSING ON TRIGGER AND ACUPUNCTURE POINTS
- TOPICAL APPLICATION OF OZONIZED WATER: HYDROZONE THERAPY, SAUNA, OZONIZED OILS AND CREAMS
13.1 Hydrozone Therapy
13.2 Ozonation of oils and obtaining terpenes
13.3 Ozone saunas
- INTRAOSSEOUS OZONE INFILTRATION (IOO3 T) TOPICAL AND SYSTEMIC ROUTE
14.1 Indications
14.2 Advantages
14.3 Contraindications
14.4 Type of needles
14.5 Sie of injection
14.6 Method
14.7 Complications
14.8 IOO3 T Administration of SSO3 under microbubling
14.9 Recommended Clinical Protocol
14.10 Protocol Used in the Treatment of Acute Infections (e.g. Osteomyelitis).
- APPLICATION ROUTES NOT RECOMMENDED DUE TO BEING UNSAFE
- ROUTES OF ADMINISTRATION THAT SHOULD NOT BE USED UNDER ANY CIRCUMSTANCES.
16.1. Inhalation Route
16.2. Direct Intravenous Injection (DIV)
16.3. High Dose Hyperbaric Multistep Method (OHT)
16.4. Intravenous Injection of Ozonized Glucose Solution
16.5. Autohemotherapy with Syringes
16.6. Ozonation of Saline Solution in a Plastic Bag with a Syringe by Beating the Bag
16.7. Intra-articular, Intravenous, or Fatty Tissue Injection of Ozonized Distilled Water Injection
- APPLICATION ROUTES THAT HAVE NOT RECEIVED CONSENSUS.
17.1. Intraperitoneal route
17.2. Blood Irradiation during MAH
- PATHOLOGIES MOST APPROPRIATE TO BE TREATED WITH OZONE.
18.1. Grades of Recommendation
18.2. Diseases in Level A
18.3. Diseases in Level B
18.4. Diseases in Level C
- GENERAL BASES FOR OZONE TREATMENT.
19.1 Essential Requirements
19.2 Basic Rules for Ozone Therapy
———–
ADDENDUM A
APPLICATIONS OF OZONE IN DENTISTRY
THERAPEUTIC RANGES FOR THE USE OF OZONE IN DENTRISTRY
INDEX
- INTRODUCTION
- BASIC PRINCIPLES
2.1. Safety precautions
2.2. Ozone, Ozonized Water and Oils, and Related Factors
2.3. Oxygen Source Dilemma
2.4. Ozone-Compatible Materials
2.5. Ozonized Bidistilled Water
2.6. Ozonized Oils
2.7. The Concept of Disinfection Kinetics
2.8. Ozone Ranges and Concentrations of Ozonated Water
2.9. Introduction of Microbubbling Ozonized Saline Solution in Dentistry
- CLASSIFICATION OF DENTAL OZONE APPLICATIONS ACCORDING TO EVIDENCE-BASED MEDICINE
- GENERAL CLINICAL INDICATIONS
4.1. Caries
4.1.1. Low-Severity Clinical Cases: Developmental Defects; Hypocalcification; Enamel-Only Caries; Partially Erupted Posterior Teeth
4.1.2. Moderate Severity Clinical Cases: Dentin Caries Affecting the Upper Third of the Crown……………
4.1.3. Moderate-High Severity Clinical Cases: Dentin Caries Affecting the Middle Third of the Crown
4.1.4. High Severity Clinical Cases: Caries in the Apical Third of Dentin
- HYPERSENSITIVITY: NOT ASSOCIATED WITH CARIES
5.1. Radicular Root Canal Treatment amiento de Conducto Radicular
5.2. Regular Hygiene/Prophylaxis and Root Scaling
5.3. Periodontal Conditions
5.3.1. Gingivitis
5.3.2. Periodontitis
- ORTHODONTICS
- ORAL SURGERY
7.1. Pre-Surgical Conditioning
7.2. Ozone Activated PRP
7.3. Dental Extractions
7.4. Implants
7.5. Mucositis
7.6. Oral-sinus communication
- CROWNS AND BRIDGES, VENEERS
- SOFT TISSUE INJURIES
- DENTAL WHITENING WITH OZONE
- MAXILLARY OSTEONECROSIS
- TEMPOROMANDIBULAR DISORDERS (TMD)
12.1. Biological foundations of ozone action in DTM
12.2. DTM Indications for ozone therapy in TMD
12.3. Preliminary evaluation and diagnostic criteria
12.4. Main symptoms associated with TMD
12.5. Recommended therapeutic approach
12.6. Joint pain (arthralgia, synovitis, capsulitis, intra-articular post-surgery)
- REGISTRATION AND DOCUMENTATION
- BIOSECURITY. WATER LINES IN THE DENTAL UNIT (LAUD) – WATER HEALTH THROUGHOUT THE DENTAL OFFICE
———–
ADDENDUM B
APPLICATIONS OF OZONE IN VETERINARY MEDICINE
THERAPEUTIC RANGES FOR THE USE OF OZONE IN VETERINARY MEDICINE AND CLINICAL APPLICATIONS
Guides for Small and Large Animals
INDEX
- INTRODUCTION
2. MAIN SYSTEMIC APPLICATION ROUTES
2.1. Major Autohemotherapy (MAH)
2.2. Minor Autohemotherapy (MiAH)
2.3. Rectal Insufflation (RIO3)
2.4. Ozonized Saline Solution (O3SS)
2.4.1. Table 1. Relationship between Species and Circulating Blood Volume for Calculating the Volume of O3SS to be Administered.
2.4.2. Table 2. Calculation O3SS Doses in Veterinary.
2.4.3. Table 3. Example of Calculating Ozone Concentration in O3SS
and Volume of O3SS to Infuse.
3. LOCAL ROUTES OF ADMINISTRATION: SUBCUTANEOUS, INTRALESIONAL, BAGGING, VESICOURETHRAL-VAGINAL, INTRAARTICULAR, PARAVERTEBRAL, TRIGGER POINTS, OTIC, OZONATED OIL.
3.1. Subcutaneous
3.2. Intralesional
3.3. Bagging
3.4. Vesicourethral-Vaginal Route
3.5. Intraarticular, Paravertebral, Trigger Point pathways
3.6. Otic Route
3.7. Topical Application of Ozonized Oil
4. ADMINISTRATION ROUTES THAT SHOULD NOT BE USED UNDER ANY CIRCUMSTANCES
4.1. Nasal Inhalation
4.2. Intra-arterial injection
4.3. Direct Intravenous Ozone Injection
4.4. Intravenous Administration of Ozonized Glucose Serum
4.5. Ozonation of Saline Solution in a Plastic Bag with a Syringe by Beating the Bag
5. PATHS THAT HAVE NOT RECEIVED CONSENSUS AND ARE NOT
RECOMMENDED
5.1. Distilled Water Injection, Double-distilled Ozonized Intra-articular or Intravenous
6. MOST COMMON ROUTES OF ADMINISTRATION IN VETERINARY MEDICINE
6.1. Table 4. Main Application Routes of Ozone in Veterinary Medicine
- MOST FREQUENT PATHOLOGIES TREATED WITH OZONE
7.1 Table 5. Most Frequent Pathologies Treated with Ozone in Veterinary Medicine
Table 5.1. Digestive Diseases
Table 5.2. Hematological Diseases
Table 5.3. Hepatic Diseases
Table 5.4. Nephrological Diseases
Table 5.5. Oncology
Table 5.6. Odontology
Table 5.7. Endocrine Diseases
Table 5.8. Ophthalmology
Table 5.9. Cardiorespiratory
Table 5.10. Genitourinary Diseases
Table 5.11. Dermatology
Table 5.12. Neurology
Table 5.13. Traumatology.
8. OZONE THERAPY IN EQUINES AND CATTLE
8.1. Systemic Routes
8.1.1. Major Autohemotherapy (MAH)
8.1.2. Minor Autohemotherapy (MiAH)
8.1.3. Rectal Insufflation (RiO3)
8.1.4. Vaginal Insufflation (VIO3)
8.1.5. Ozonized Saline Solution (O3SS)
8.2. Local Routes.
8.2.1. Distilled/Double-distilled Ozonized Water
8.2.2. Intramammary Infiltration
8.2.3. Bagging
8.2.4. Ozonized oil
8.2.5. Intraarticular Infiltration
8.2.6. Intraperitoneal
8.2.7. Infiltration in Oncology
8.2.8. Fistulas
8.2.9. Subcutaneous Administration
8.2.10. Intradiscal
8.2.11. Paravertebral/Intramuscular
8.2.11. Paravertebral/Intramuscular - VARIOUS APPLICATIONS IN EQUINES
Table 6. Ozone application in Equines
Table 6.1. Laminitis
Table 6.2. Navicular Syndrome
Table 6.3. Pythiosis
Table 6.4. Myositis
Table 6.5. Intraarticular Infiltration
Table 6.6. Septic Arthritis
Table 6.7. Desmitis and Tendinitis
Table 6.8. Low Back Pain and Spinal Injury
Table 6.9. Muscle Atrophy
Table 6.10. Atrial Papillomavirus
6.11. Cutaneous Papillomavirus
Table 6.12. Idiopathic Dermatitis. Allergies
Table 6.13. Various Dermatitis
Table 6.14. Kerato Conjunctivitis
Table 6.15. Neonatal Hypoxemic Syndrome
Table 6.16. Foal Pneumonia
Table 6.17. Foal Diarrhea
Table 6.18. Herpes Virus
Table 6.19. Transient Management of Acute Intra-abdominal Abdomen Syndrome
Table 6.20. Peritonitis
Table 6.21. Peritesticular
Table 6.22. Post-Sochiectomy Fistula
Table 6.23. Postorchiectomy
Table 6.24. Intravaginal
Table 6.25. Chronic Intrauterine Endometritis
Table 6.26. Subclinical or Inflammatory Intrauterine Endometritis
Table 6.27. Improvement of Oogenesis and Spermatogenesis
Table 6.28. Perineoplasty
Table 6.29. Vulvoplasty
Table 6.30. Rectovaginal Fistula
Table 6.31. Gastric and/or Duodenal Ulcer
Table 6.32. Pododermatitis
Table 6.33. Subsolar Abscess
Table 6.34. Drainage of Abscesses
Table 6.35. Extraction
Table 6.36. Dental Fistula
Table 6.37. Athletic Performance
Table 6.38. Intravesical
Table 6.39. Wounds
This content is also available in: Spanish

